相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
Ye V. Liu et al.
VACCINE (2011)
Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice
Baojing Lu et al.
IMMUNOLOGY (2010)
Immunogenicity and Protective Efficacy in Mice and Hamsters of a β-Propiolactone Inactivated Whole Virus SARS-CoV Vaccine
Anjeanette Roberts et al.
VIRAL IMMUNOLOGY (2010)
A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity
Lanying Du et al.
VIRAL IMMUNOLOGY (2010)
A Novel Histologic Scoring System to Evaluate Mucosal Biopsies From Patients With Eosinophilic Esophagitis
Cheryl Protheroe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Differential Virological and Immunological Outcome of Severe Acute Respiratory Syndrome Coronavirus Infection in Susceptible and Resistant Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2
Naoko Yoshikawa et al.
JOURNAL OF VIROLOGY (2009)
Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines
Raymond H. See et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
Fumihiko Yasui et al.
JOURNAL OF IMMUNOLOGY (2008)
A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in Golden Syrian hamsters
Elaine W. Lamirande et al.
JOURNAL OF VIROLOGY (2008)
Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
Kumari G. Lokugamage et al.
VACCINE (2008)
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Julie E. Martin et al.
VACCINE (2008)
Viral and host factors in human respiratory syncytial virus pathogenesis
Peter L. Collins et al.
JOURNAL OF VIROLOGY (2008)
GlaxoSmithKline Adjuvant systems in vaccines: concepts, achievements and perspectives
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2007)
Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 virus receptor
Chien-Te K. Tseng et al.
JOURNAL OF VIROLOGY (2007)
Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease
Elaine M. Castilow et al.
IMMUNOLOGIC RESEARCH (2007)
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
Damon Deming et al.
PLOS MEDICINE (2006)
A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice
ZM Zhou et al.
VACCINE (2006)
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus
RH See et al.
JOURNAL OF GENERAL VIROLOGY (2006)
A double-inactivated whole virus candidate SARS coronavirus vaccine
M Spruth et al.
VACCINE (2006)
Immunopathogenesis of coronavirus infections: Implications for SARS
S Perlman et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Bats are natural reservoirs of SARS-like coronaviruses
WD Li et al.
SCIENCE (2005)
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice
K Subbarao et al.
JOURNAL OF VIROLOGY (2004)
Mice susceptible to SARS coronavirus
DE Wentworth et al.
EMERGING INFECTIOUS DISEASES (2004)
Promotion of B cell immune responses via an alum-induced myeloid cell population
MB Jordan et al.
SCIENCE (2004)
Current concepts: The severe acute respiratory syndrome
JSM Peiris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Critically ill patients with severe acute respiratory syndrome
RA Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
A cluster of cases of severe acute respiratory syndrome in Hong Kong
KW Tsang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Identification of severe acute respiratory syndrome in Canada
SM Poutanen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A major outbreak of severe acute respiratory syndrome in Hong Kong
N Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A role for immune complexes in enhanced respiratory syncytial virus disease
FP Polack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice
UF Power et al.
JOURNAL OF VIROLOGY (2001)
分享论文
